{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T18:53:31Z","timestamp":1698778411185},"reference-count":29,"publisher":"Japanese Society of Veterinary Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1292\/jvms.68.367","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T05:45:49Z","timestamp":1146807949000},"page":"367-371","source":"Crossref","is-referenced-by-count":1,"title":["A Comparison of Biodistribution between 111In-DTPA Octreotide and 111In-DOTATOC in Rats Bearing Pancreatic Tumors"],"prefix":"10.1292","volume":"68","author":[{"given":"Yung-Chang","family":"LIN","sequence":"first","affiliation":[{"name":"Veterinary Medical Teaching Hospital, National Chung-Hsing University"},{"name":"Department of Veterinary Medicine, National Chung-Hsing University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Uei","family":"HUNG","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Changhua Christian Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Yueh","family":"LUO","sequence":"additional","affiliation":[{"name":"Isotope Application Division, Institute of Nuclear Energy Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hsiung","family":"CHEN","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, National Chung-Hsing University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chung","family":"HSIA","sequence":"additional","affiliation":[{"name":"Isotope Application Division, Institute of Nuclear Energy Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ling","family":"HEN","sequence":"additional","affiliation":[{"name":"Isotope Application Division, Institute of Nuclear Energy Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Jen","family":"HO","sequence":"additional","affiliation":[{"name":"Department of Radiology, China Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Yu","family":"LIN","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Taichung Veterans General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"issue":"12","key":"1","first-page":"1929","volume":"38","year":"1997","journal-title":"J. Nucl. Med.","ISSN":"http:\/\/id.crossref.org\/issn\/0161-5505","issn-type":"print"},{"issue":"1","key":"2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/bj2650039","volume":"265","year":"1990","journal-title":"Biochem. J.","ISSN":"http:\/\/id.crossref.org\/issn\/0264-6021","issn-type":"print"},{"key":"3","unstructured":"3. Cremonesi, M., Ferrari, M., Chinol, M., Bartolomei, M., Stabin, M. G., Sacco, E., Fiorenza, M., Tosi, G. and Paganelli, G. 2000. Dosimetry in radionuclide therapies with 90Y-conjugates: the IEO experience. J. Nucl. Med. 44: 325-332."},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980130)75:3<406::AID-IJC14>3.0.CO;2-6"},{"key":"5","unstructured":"5. Foekens, J. A., Portengen, H., van Putten, W. L., Trapman, A. M., Reubi, J. C., Alexieva-Figusch, J. and Klijn, J. G. 1989. Prognostic value of receptors for insulin-like growth factor 1, somatostatin and epidermal growth factor in human breast cancer. Cancer 49: 7002-7009."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Forster, G. J., Engelbach, M. J., Brockmann, J. J., Reber, H. J., Buchholz, H. G., Macke, H. R., Rosch, F. R., Herzog, H. R. and Bartenstein, P. R. 2001. Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide. Eur. J. Nucl. Med. 28: 1743-1750.","DOI":"10.1007\/s002590100628"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Froidevaux, S., Heppeler, A., Eberle, A. N., Meier, A. M., Hausler, M., Beglinger, C., Behe, M., Powell, P. and Macke, H. R. 2000. Preclinical comparison in AR4-2J tumor bearing mice of four radiolabeled DOTA-somatostatin analogs for tumor diagnosis and internal radiotherapy. Endocrinology 141: 3304-3312.","DOI":"10.1210\/endo.141.9.7683"},{"issue":"15","key":"8","first-page":"3652","volume":"59","author":"FROIDEVAUX S","year":"1999","journal-title":"Cancer Res.","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Garden, O. A., Reubi, J. C., Dykes, N. L., Yeager, A. E., McDonough, S. P. and Simpson, K. W. 2005. Somatostatin receptor imaging <i>in vivo<\/i> by planar scintigraphy facilitates the diagnosis of canine insulinomas. J. Vet. Intern. Med. 19: 168-176.","DOI":"10.1111\/j.1939-1676.2005.tb02678.x"},{"issue":"6","key":"10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/bjc.1993.266","volume":"67","year":"1993","journal-title":"Br. J. Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/0007-0920","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hofland, L. J. and Lamberts, S. W. 1996. Somatostatin receptors and disease: role of receptor subtypes. Clin. Endocrinol. Metab. 10: 163-176.","DOI":"10.1016\/S0950-351X(96)80362-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Jowsey, J., Rowland, R. E. and Marshall, J. H. 1958. The deposition of the rare earths in bone. Radiat. Res. 8: 490-501.","DOI":"10.2307\/3570441"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A., Kooij, P. P., Oei, H. Y., van Hagen, M., Postema, P. T., de Jong, M. and Reubi, J. C. 1993. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1,000 patients. Eur. J. Nucl. Med. 20: 716-731.","DOI":"10.1007\/BF00181765"},{"key":"14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1749-6632.1994.tb17291.x","volume":"733","year":"1994","journal-title":"Ann. New York Acad. Sci.","ISSN":"http:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kwekkeboom, D. J., Bakker, W. H., Kam, B. L., Teunissen, J. J., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., de Jong, M., Srinivasan, A., Erion, J. L. and Krenning, E. P. 2003. Treatment of patients with gastro-entero-pancreatic (GEP) tumors with the novel radiolabelled somatostatin analogue [177Lu-DOTA, Tyr3]octreotate. Eur. J. Nucl. Med. Mol. Imaging 30: 417-422.","DOI":"10.1007\/s00259-002-1050-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lamberts, S. W., van der Lely, A. J., de Herder, W. W. and Holland, L. 1996. Drug therapy-octreotide. New Engl. J. Med. 334: 246-254.","DOI":"10.1056\/NEJM199601253340408"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Li, S., Kurtaran, A., Li, M., Traub-Weidinger, T., Kienast, O., Schima, W., Angelberger, P., Virgolini, I., Raderer, M. and Dudczak, R. 2003. 111In-DOTA-DPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualization of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study. Eur. J. Nucl. Med. Mol. Imaging 30: 1087-1095.","DOI":"10.1007\/s00259-003-1206-1"},{"issue":"1","key":"18","first-page":"13","volume":"36","year":"1995","journal-title":"J. Nucl. Med.","ISSN":"http:\/\/id.crossref.org\/issn\/0161-5505","issn-type":"print"},{"key":"19","unstructured":"19. Macke, B&eacute;h&eacute;. M., Froidevaux, S., Heppler, A. and Jermann, E. 1997. DOTA-D-Phe(1)-Tyr(3)-octreotide (DOTATOC): a unique somatostatin receptor ligand for labelling with a variety of metallic radionuclides. J. Nucl. Med. 38: 18P."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Otte, A., Jermann, E., Behe, M., Goetze, M., Bucher, H. C., Roser, H. W., Heppeler, A., Mueller-Brand, J. and Maecke, H. R. 1997. DOTATOC-a new powerful tool for receptor-mediated radionuclide therapy. Eur. J. Nucl. Med. 24: 792-795.","DOI":"10.1007\/BF00879669"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Paganelli, G., Zoboli, S., Cremonesi, M., Bodei, L., Ferrari, M., Grana, C., Bartolomei, M., Orsi, F., De Cicco, C., Macke, H. R., Chinol, M. and de Braud, F. 2001. Receptor-mediated radiotherapy with Y-90-DOTA-D-Phe1-Tyr3-octreotide. Eur. J. Nucl. Med. 28: 426-434.","DOI":"10.1007\/s002590100490"},{"key":"22","unstructured":"22. Reubi, J. C., Horisberger, U., Lang, W., Koper, J. W., Braakman, R. and Lamberts, S. W. 1989. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumours. Am. J. Pathol. 134: 337-344."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Reubi, J. C., Schar, J. C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S. and Macke, H. R. 2000. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur. J. Nucl. Med. 27: 273-282.","DOI":"10.1007\/s002590050034"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Robben, J. H., Pollak, Y. W., Kirpensteijn, J., Boroffka, S. A., van den Ingh, T. S., Teske, E. and Voorhout, G. 2005. Comparison of ultrasonography, computed tomography, and single-photon emission computed tomography for the detection and localization of canine insulinoma. J. Vet. Intern. Med. 19: 15-22.","DOI":"10.1892\/0891-6640(2005)19<15:COUCTA>2.0.CO;2"},{"key":"25","unstructured":"25. Rowlinson, G., Snook, D., Stewart, S. and Epenetos, A. A. 1989. Intravenous EDTA to reduce bone uptake of Y-90 following Y-90 labeled antibody administration. Br. J. Cancer 59: 322."},{"key":"26","unstructured":"26. Slooter, G. D., Mearadji, A., Breeman, W. A., Marquet, R. L., de Jong, M., Krenning, E. P. and van Eijck, C. H. 2001. Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours. Br. Surg. 88: 31-40."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Stoltz, B., Weckebecker, G., Smith-Jones, P., Albert, R., Raulf, F. and Bruns, C. 1998. The somatostatin receptor-targeted radiotherapeutic [90 Y-DOTA-DPhe 1, Tyr 3] octreotide (90 Y-SMT 487) eradicates experimental rat pancreatic CA 20,948 tumours. Eur. J. Nucl. Med. 25: 668-674.","DOI":"10.1007\/s002590050268"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Virgolini, I., Patri, P., Novotny, C., Traub, T., Leimer, M., Fuger, B., Li, S. R., Angelberger, P., Raderer, M., Wogritsch, S., Kurtaran, A., Kletter, K. and Dudczak, R. 2001. Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy. Ann. Oncol. 12: supplement 41-45.","DOI":"10.1093\/annonc\/12.suppl_2.S41"},{"key":"29","unstructured":"29. Waldherr, C., Pless, M., Maecke, H., Schumachjer, T., Crazzolara, A., Nitzsche, E., Haldemann, A. and Mueller-Brand, J. 2002. Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq Y-90 DOTATOC. J. Nucl. Med. 43: 610-616."}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jvms\/68\/4\/68_4_367\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T01:57:37Z","timestamp":1617069457000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jvms\/68\/4\/68_4_367\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.68.367","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}